Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
InhaleRx Limited ( (AU:IRX) ) has issued an announcement.
InhaleRx Limited has announced a shareholder town hall webinar scheduled for March 13, 2025, where the company’s CEO and Medical Advisor will provide updates on recent developments and progress in their clinical development program. This event highlights InhaleRx’s ongoing efforts to strengthen its position in the healthcare industry by addressing unmet medical needs and pursuing significant economic opportunities for its shareholders.
More about InhaleRx Limited
InhaleRx Limited is an Australian healthcare company focused on developing unique inhaled drug-device products targeting unmet medical needs in the pain management and mental health sectors. The company aims to secure U.S. FDA approval through rapid and cost-effective regulatory pathways, with a focus on Breakthrough Cancer Pain and Panic Disorder, both of which have limited treatment options.
YTD Price Performance: -32.50%
Average Trading Volume: 114,607
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$5.76M
For a thorough assessment of IRX stock, go to TipRanks’ Stock Analysis page.